Anticorps Polyclonal de lapin anti-DGCR8 C-terminal

• Phare
• Validé par KD/KO

DGCR8 C-terminal Polyclonal Antibody for FC, IF, IHC, IP, WB, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, souris et plus (1)

Applications

WB, RIP, IP, IHC, IF, FC, CoIP, ChIP, ELISA

Conjugaison

Non conjugué

Publications

84

N° de cat : 10996-1-AP

Synonymes

C22orf12, DGCR8, DGCR8 C-terminal, DGCRK6, Gy1

---

Galerie de données de validation

• 

  WB analysis using 10996-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 10996-1-AP (DGCR8 C-terminal antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of mouse testis using 10996-1-AP

  mouse testis tissue were subjected to SDS PAGE followed by western blot with 10996-1-AP (DGCR8 C-terminal antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of Jurkat using 10996-1-AP

  Jurkat cells were subjected to SDS PAGE followed by western blot with 10996-1-AP (DGCR8 C-terminal antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of A431 using 10996-1-AP

  A431 cells were subjected to SDS PAGE followed by western blot with 10996-1-AP (DGCR8 C-terminal antibody) at dilution of 1:800 incubated at room temperature for 1.5 hours.

• 

  IP experiment of HEK-293 using 10996-1-AP

  IP Result of anti-DGCR8 C-terminal (IP:10996-1-AP, 3ug; Detection:10996-1-AP 1:800) with HEK-293 cells lysate 2700ug.

• 

  IHC staining of human breast cancer using 10996-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer using 10996-1-AP (DGCR8 C-terminal antibody) at dilution of 1:100 (under 40x lens).

• 

  IHC staining of human breast cancer using 10996-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer using 10996-1-AP (DGCR8 C-terminal antibody) at dilution of 1:100 (under 10x lens).

• 

  IHC staining of human breast cancer using 10996-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer using 10996-1-AP (DGCR8 C-terminal antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human colon cancer using 10996-1-AP

  Immunohistochemical analysis of paraffin-embedded human colon cancer using 10996-1-AP (DGCR8 C-terminal antibody) at dilution of 1:50 (under 40x lens).

• 

  IF Staining of SH-SY5Y using 10996-1-AP

  Immunofluorescent analysis of SH-SY5Y cells, using DGCR8 antibody 10996-1-AP at 1:50 dilution and FITC-labeled donkey anti-rabbit IgG(green). Blue pseudocolor = DAPI (fluorescent DNA dye).

• 

  FC experiment of HeLa using 10996-1-AP

  1X10^6 HeLa cells were stained with 0.2ug DGCR8 C-terminal antibody (10996-1-AP, red) and control antibody (blue). Alexa Fluor 488-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) with dilution 1:1000. Cells were fixed with 4% PFA and permeabilized with 0.1% Triton X-100.

• 

  FC experiment of SH-SY5Y using 10996-1-AP

  1X10^6 SH-SY5Y cells were stained with 0.2ug DGCR8 C-terminal antibody (10996-1-AP, red) and control antibody (blue). Fixed with 90% MeOH blocked with 3% BSA (30 min). Alexa Fluor 488-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) with dilution 1:100.

---

Applications testées

• Résultats positifs en WB: cellules HEK-293, cellules A431, cellules HeLa, cellules Jurkat, tissu testiculaire de souris
• Résultats positifs en IP: cellules HEK-293
• Résultats positifs en IHC: tissu de cancer du sein humain, tissu de cancer du côlon humain; il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
• Résultats positifs en IF: cellules SH-SY5Y
• Résultats positifs en cytométrie: cellules HeLa, cellules SH-SY5Y

Dilution recommandée

• Western Blot (WB): WB : 1:500-1:2000
• Immunoprécipitation (IP): IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
• Immunohistochimie (IHC): IHC : 1:50-1:200
• Immunofluorescence (IF): IF : 1:20-1:200
• Flow Cytometry (FC): FC : 0.20 ug per 10^6 cells in a 100 µl suspension

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• KD/KO: See 15 publications below
• WB: See 74 publications below
• IHC: See 5 publications below
• IF: See 9 publications below
• IP: See 3 publications below
• CoIP: See 2 publications below
• ChIP: See 1 publications below
• RIP: See 4 publications below

Informations sur le produit

10996-1-AP cible DGCR8 C-terminal dans les applications de WB, RIP, IP, IHC, IF, FC, CoIP, ChIP, ELISA et montre une réactivité avec des échantillons Humain, souris

• Réactivité: Humain, souris
• Réactivité citée: rat, Humain, souris
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: DGCR8 C-terminal Protéine recombinante Ag1429
• Nom complet: DiGeorge syndrome critical region gene 8
• Masse moléculaire calculée: 773 aa, 86 kDa
• Poids moléculaire observé: 120 kDa
• Numéro d’acquisition GenBank: BC009323
• Symbole du gène: DGCR8
• Identification du gène (NCBI): 54487
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

DGCR8 is a RNA-binding protein that assists the Rnase III enzyme Drosha in the processing of microRNAs (miRNAs), which regulate the expression of a large number of protein-coding genes[PMID: 22580560]. DGCR8, which contains two double-stranded RNA (dsRNA)-binding domains, may be an essential component of the primary miRNAs processing complex, along with Drosha, promoting the processing of primary microRNA to precursor microRNA. It is ubiquitous expressed in human and mouse tissues, and is deleted in DiGeorge syndrome[22323604]. The calculated molecular weight of DGCR8 is 82-86 kDa, but the post-modified DGCR8 is about 120 kDa (PMID: 18469815).

Publications

Species	Application	Title
mouse,human	WB,IF	Nature; Global miRNA dosage control of embryonic germ layer specification.; Authors - Yingzi Cui ; KO Validated
human	WB	Nature; Modulation of microRNA processing by p53.; Authors - Suzuki Hiroshi I HI
human	WB	Cell; Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms.; Authors - Piskounova Elena E
human	WB	Cell; Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.; Authors - Masaki Mori
mouse	ChIP	Cell; Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis.; Authors - Hiroshi I Suzuki
human	WB	Cell Stem Cell; Principles of signaling pathway modulation for enhancing human naive pluripotency induction.; Authors - Jonathan Bayerl

Produits associés

Drosha Polyclonal antibody

55001-1-AP

GEMIN4 Polyclonal antibody

12408-1-AP

RAN Polyclonal antibody

10469-1-AP

DICER1 Polyclonal antibody

20567-1-AP

EIF2C1-Specific Polyclonal antibody

19690-1-AP

AGO2 Polyclonal antibody

10686-1-AP

CNOT1 Polyclonal antibody

14276-1-AP